ParacetamolAlso known as acetaminophen
Common medicine part of whose effect is attributed, in rodents, to AM404, a brain metabolite acting on TRPV1.
C₈H₉NO₂
CAS 103-90-2
- Family
- ECS pharmacological toolOther target
- Molar mass
- 151.16 g/mol
Updated on
In plain terms
Paracetamol is a common medicine for pain and fever, available without a prescription. Its mechanism was long poorly understood. In mice and rats, part of its effect goes through a compound made in the brain, AM404, which resembles the cannabinoids produced by the body. It is not a cannabinoid: it is an ordinary medicine from which the body makes, in small part, a related molecule.
Receptors and activity
Target network
- Activates
- Binds or modulates
The lower the cited value, the closer the target sits to Paracetamol: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of Paracetamol.
TRPV1TRPV1 found in 7 regions of the body
- Sensory gangliapresentExpressed in dorsal root ganglia1
- Spinal cordpresentNerve fibres in the spinal dorsal horn2
- CortexpresentParietal cortex neurons (layers 3 and 5)3
- SkinpresentWidely distributed in the skin4
- Blood vesselspresentPresent on dermal blood vessels4
- BonepresentPresent on osteoclasts5
- LiverpresentRNA enriched in the liver6
Map sources
- Cortright DN et al. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun, 2001 (new tab)
- Facer P et al. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol, 2007 (new tab)
- Mezey E et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A, 2000 (new tab)
- Ständer S et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol, 2004 (new tab)
- Rossi F et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone, 2009 (new tab)
- Human Protein Atlas. TRPV1 tissue expression (RNA consensus) (new tab)
Cited values
- TRPV1Agonistno measured value cited
indirect effect: the metabolite AM404 is a potent TRPV1 agonist; paracetamol is not itself the ligand; the effect of 4-aminophenol is abolished in TRPV1-deficient mice (Högestätt et al. 2005; Barrière et al. 2013)
- FAAHModulatorno measured value cited
enzyme not inhibited but required for AM404 formation (conjugation of 4-aminophenol to arachidonic acid); absent in FAAH-deficient mice (Högestätt et al. 2005)
- CB1Modulatorno measured value cited
no direct binding reported; the antinociceptive effect of 4-aminophenol in the rat is prevented by a CB1 antagonist (Barrière et al. 2013)
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of Paracetamol, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Paracetamol occupies an unexpected place in an encyclopaedia of cannabinoids. An analgesic and antipyretic used as a medicine, it is not itself a cannabinoid; what links it here is its metabolism. In 2005, Högestätt and colleagues (Lund University) showed that after deacetylation to the primary amine, it is conjugated with arachidonic acid in the brain and spinal cord to form AM404, a potent TRPV1 agonist: the reaction depends on FAAH, the enzyme that usually breaks down anandamide, and it is absent in mice lacking this enzyme. AM404 also inhibits purified COX-1 and COX-2 and acts on the endogenous cannabinoid system (Högestätt et al. 2005). In 2013, Barrière and colleagues studied 4-aminophenol, the deacetylated metabolite of paracetamol: in mice, its antinociceptive effect and the formation of AM404 depend on FAAH, and its effect depends on TRPV1; in rats, it is prevented by blocking CB1, spinal 5-HT3 or 5-HT1A receptors, or by deleting bulbospinal serotonergic pathways. As the profile is identical to that reported for paracetamol, the authors propose that this metabolite contributes to the drug's analgesic activity through bulbospinal pathways (Barrière et al. 2013). This is a mechanistic hypothesis established in rodents, not a demonstration in humans.
Key sources.
- Högestätt et al., J Biol Chem 2005: conversion of acetaminophen to the bioactive N-acylphenolamine AM404 by FAAH-dependent arachidonic acid conjugation in the nervous system (new tab)PMID 15987694
- Barrière et al., PLoS One 2013: FAAH-dependent generation of antinociceptive metabolites acting at TRPV1 in the brain (study of 4-aminophenol and HMBA) (new tab)PMID 23940628
- PubChem, paracetamol, CID 1983: sections « Absorption, Distribution and Excretion », « Metabolism/Metabolites », « Biological Half-Life », « Antidote and Emergency Treatment » and « Drug Warnings » (HSDB and DrugBank extracts) (new tab)
- ANSM, end of open-shelf access to paracetamol- and NSAID-based medicines on 15 January 2020 (new tab)
- ANSM, consolidated list of narcotics, updated 16 February 2026 (text reviewed) (new tab)
- Council Framework Decision 2004/757/JHA, annex, consolidated version of 12 January 2026 (EUR-Lex) (new tab)
History
- Source
- Synthetic molecule, manufactured industrially as a medicinal active ingredient. It is not of cannabis origin and does not belong to the phytocannabinoids: it appears here because, in rodents, part of its antinociceptive effect is attributed to a metabolite that acts on TRPV1 and on the endogenous cannabinoid system (Högestätt et al. 2005; Barrière et al. 2013).
Origin
Research tool
Synthetic molecule, described here by class: a simple aromatic amide, N-(4-hydroxyphenyl)acetamide, that is, a phenol ring bearing an acetamide group in the para position. Its transformation in the body is the notable point: after deacetylation to the primary amine (4-aminophenol), this is conjugated with arachidonic acid, by a FAAH-dependent reaction, to form AM404 in the brain and spinal cord (Högestätt et al. 2005).
Legal framework
- European Union
The substance is not listed in the Annex to Council Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which lists the new psychoactive substances controlled at European Union level; control is a matter for national law. Paracetamol is a medicine with marketing authorisations, not a controlled psychoactive substance.
- France
A medicine with marketing authorisations, available without a prescription, and not listed in the ANSM consolidated list of narcotics (updated 16/02/2026; no occurrence of paracetamol, acetaminophen or AM404). According to the ANSM, since 15 January 2020 medicines containing paracetamol can no longer be displayed in free access in pharmacies and must be placed behind the counter; they remain available without a prescription, and the measure aims to promote their proper use.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Other target
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Högestätt et al., J Biol Chem 2005: conversion of acetaminophen to the bioactive N-acylphenolamine AM404 by FAAH-dependent arachidonic acid conjugation in the nervous system (new tab)PMID 15987694
- Barrière et al., PLoS One 2013: FAAH-dependent generation of antinociceptive metabolites acting at TRPV1 in the brain (study of 4-aminophenol and HMBA) (new tab)PMID 23940628
- PubChem, paracetamol, CID 1983: sections « Absorption, Distribution and Excretion », « Metabolism/Metabolites », « Biological Half-Life », « Antidote and Emergency Treatment » and « Drug Warnings » (HSDB and DrugBank extracts) (new tab)
- ANSM, end of open-shelf access to paracetamol- and NSAID-based medicines on 15 January 2020 (new tab)
- ANSM, consolidated list of narcotics, updated 16 February 2026 (text reviewed) (new tab)
- Council Framework Decision 2004/757/JHA, annex, consolidated version of 12 January 2026 (EUR-Lex) (new tab)
Identifiers
Names
- Common name
- Paracetamol (acetaminophen)
- IUPAC name
- N-(4-hydroxyphenyl)acetamide
- Other names
- Acetaminophen · APAP
Identifiers
- Formula
- C₈H₉NO₂
- CAS
- 103-90-2
- PubChem CID
- 1983(new tab)
- ChEBI
- 46195(new tab)
- InChIKey
- RZVAJINKPMORJF-UHFFFAOYSA-N
- SMILES
- CC(=
O) NC1= CC= C(C= C1) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.